Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. (Q53912257)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. |
scientific article |
Statements
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. (English)
1 reference
Eron JJ
1 reference
Yetzer ES
1 reference
Ruane PJ
1 reference
Becker S
1 reference
Sawyer GA
1 reference
Fisher RL
1 reference
Tolson JM
1 reference
Shaefer MS
1 reference
1 April 2000
1 reference
1 reference
14
1 reference
6
1 reference
671-681
1 reference
Identifiers
1 reference